Evaluating inflammation changes in patients after heart rhythm procedure
Official title: Change in Inflammatory State in Patients Undergoing Transcatheter Ablation of Atrial Fibrillation
Run by Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · NCT05961865 · Data updated 2026-11-12
This study looks at how inflammation and fat levels change in people aged 18 to 85 after they have a heart procedure to treat atrial fibrillation.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 85 Years |
| Sex | All |
| Enrollment | 180 (estimated) |
| Sponsor | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico Academic / other |
| Locations | 1 site (Milan) |
| Status | Recruiting |
| Started | July 11, 2023 |
| Main results expected | July 2027 |
| Study ends | August 2027 |
| Registry record updated | September 13, 2023 |
| Trial ID | NCT05961865 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 to 85 with paroxysmal or persistent atrial fibrillation scheduled for catheter ablation.
✕Probably not a fit
Patients over 85 years old, those with severe comorbidities, or contraindications to the procedure may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess the relationship between inflammation markers and local fat levels in patients undergoing catheter ablation for atrial fibrillation. It will analyze various inflammation and fibrosis markers, including Interleukin 6 and tumor necrosis factor, at different time points before and after the procedure. The study will include patients aged 18 to 85 who meet specific clinical criteria and can provide informed consent.
Why it matters
Potential benefit: If successful, this study could enhance understanding of inflammation's role in atrial fibrillation and improve patient outcomes post-ablation.
How similar studies have gone: Other studies have explored inflammation in relation to atrial fibrillation, suggesting potential for meaningful insights, though this specific approach may be novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Paroxysmal or persistent AF; * Patients undergoing ESC/ERAH(European Society of Cardiology/European Heart Rhythm Association) approved catheter ablation procedures; * Aged between 18 and 85 years; * Ability to provide informed consent for study participation. Exclusion Criteria: * Age \> 85 years or \< 18 years; * Presence of left auricular thrombosis on pre-procedural transesophageal echocardiogram; * NYHA functional class IV; * Left ventricular ejection fraction \<30%; * Myocardial infarction or unstable angina or recent coronary artery bypass graft (\<6 months); * Significant co-morbidity, such as cancer, severe renal failure requiring dialysis, severe obstructive pulmonary disease, cirrhosis, with a life expectancy of less than 12 months; * Presence of contraindications to the procedure; * Inability to provide informed consent for study participation.
Where it's running
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Milan, Italy Recruiting
Study contacts
- Principal investigator: Stefano Carugo, MD — IRCCS Fondazione Cà Granda Ospedale Maggiore Policlinico
- Study coordinator: Stefano Carugo, MD
- Email: stefano.carugo@policlinico.mi.it
- Phone: +390255033532
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
HeartBeam ECG Registry: See How Heartbeat Patterns Look Across People
This registry tests HeartBeam ECG recordings in real-world patients to build a de-identified database for research.
-
RHYthm and Myocardial Function Relationship in Heart Disease
This study tests how heart rhythm patterns relate to heart muscle function in adults with arrhythmias or cardiomyopathy.
-
Using BIOMONITOR IV to track heart rhythm and warning signs in people with heart failure
This project will test whether a small implanted monitor called BIOMONITOR IV can track irregular heartbeats and body signals in people with heart failure who do not have ICD/CRT devices to see if it can warn doctors before the heart failure gets worse.
-
AI-powered ECG to detect heart disease and atrial fibrillation in routine care
This trial tests whether an AI-based ECG tool can help doctors find undiagnosed heart disease and atrial fibrillation in patients and whether using the tool changes clinical decisions and outcomes.
-
Ablation of focal activation in atrial fibrillation
This study is testing a new method to find specific electrical signals that may be causing ongoing atrial fibrillation in patients, to see if targeting these signals can improve their treatment.
-
Using a device to prevent strokes during heart procedures for atrial fibrillation
This study tests whether a special device can help prevent strokes during heart procedures for people with atrial fibrillation and see if it improves their thinking skills afterward.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.